← Back to Clinical Trials
Recruiting NCT04556019
Results of Surgical Treatment of the Hepatobiliopancreatic Surgical Unit
Trial Parameters
Condition Pancreas Disease
Sponsor Fundacion Miguel Servet
Study Type OBSERVATIONAL
Phase N/A
Enrollment 1,000
Sex ALL
Min Age 15 Years
Max Age 90 Years
Start Date 2019-01-03
Completion 2024-01
Interventions
Hepatobiliopancreatic surgery
Brief Summary
The main aims of this study are: 1. \- to evaluate post-surgical morbidity and mortality outcomes, following the criteria and the definitions from Claven-Dindo and ISGPS international classifications, of the patients operated by the HPB Surgical Unit. 2. \- to evaluate survival and disease-free survival rates of the patients operated by the HPB Surgical Unit due to tumoral cause.
Eligibility Criteria
Inclusion Criteria: * All patients operated by the HPB Surgical Unit in the last 10 years (retrospective) * All patients being operated by the HPB Surgical Unit from January 2019 onwards who provide inform consent (prospective). Exclusion Criteria: * Patients not eligible for surgery * Patients not interested in taking part in the study